The rebate game played by drug makers and pharmacy benefit managers limits optimal biosimilar competition. As a result, U.S.

The Rio-based network of independent pharmacies blames drug industry intermediaries known as pharmacy benefit managers.

GoodRx has been hit with a series of antitrust class actions in California and Rhode Island federal courts challenging the ...

“The traditional pharmacy, the dispensing model is not gonna survive,” McDonough said. While pharmacy closures are an obvious challenge to patient access, he says some pharmacies are reducing hours or ...

A handful of current Democratic House members are among the incoming senators who will face a new GOP majority in the Senate.

Donald Trump’s first term as president was characterized by significant turbulence for government healthcare programs. Here’s ...

At the top of the list are pharmacy benefit managers and the roadblocks they create for patients to access and afford necessary medications. Fortunately, since my diagnosis of Sjogren's disease, there ...

The review of Minnesota-based Optum’s business practices by the Mississippi Board of Pharmacy indicated that the company paid independent pharmacies in Mississippi rates lower than chains and ...

Pharmacy Benefit Managers are the middlemen who manage virtually all prescriptions written in the U.S. Serving as brokers among drugmakers, pharmacies, and health insurers, these health care entities ...

PENNSYLVANIA, USA — Republican incumbent Timothy DeFoor is running to keep his seat, while State Rep. Malcolm Kenyatta, ...

Third quarter net product revenues for ZORYVE® (roflumilast) franchise of $44.8M, with $22.0M for ZORYVE cream 0.3%, $20.3M for ZORYVE topical ...

Blue Shield of Calif. is bypassing traditional pharmacy benefit managers to bring a Humira-referenced biosimilar, Idacio, to ...